Matilu Mwau

HIV type 1 subtypes among STI patients in Nairobi: a genotypic study based on partial pol gene sequencing.

Rapid identification of infants for antiretroviral therapy in a resource poor setting: the Kenya experience.

Molecular genetic diversity of hepatitis B virus in Kenya.

Genetic diversity of HIV type 1 along the coastal strip of Kenya.

The effect of participant nonresponse on HIV prevalence estimates in a population-based survey in two informal settlements in Nairobi city.

HIV type 1 subtype surveillance in central Kenya.

Determinants for HIV testing and counselling in Nairobi urban informal settlements.

Discrepant test findings in early infant diagnosis of HIV in a national reference laboratory in Kenya: challenges and opportunities for programs.

Early detection of HIV infection among Kenyan infants using a reverse transcriptase activity assay.

Are slum dwellers at heightened risk of HIV infection than other urban residents? Evidence from population-based HIV prevalence surveys in Kenya.

Evaluation of clinical and immunological markers for predicting virological failure in a HIV/AIDS treatment cohort in Busia, Kenya.

Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.

Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models.

Technical performance evaluation of the MyT4 point of care technology for CD4+ T cell enumeration.

Seroprevalence of yellow fever virus in selected health facilities in Western Kenya from 2010 to 2012.

Hepatitis B, Hepatitis C and HIV-1 Coinfection in Two Informal Urban Settlements in Nairobi, Kenya.

Species-Specific Serological Detection for Schistosomiasis by Serine Protease Inhibitor (SERPIN) in Multiplex Assay.

Development of multiplex serological assay for the detection of human African trypanosomiasis.

The BD FACSPresto Point of Care CD4 Test Accurately Enumerates CD4+ T Cell Counts.

Spatial Distributions of HIV Infection in an Endemic Area of Western Kenya: Guiding Information for Localized HIV Control and Prevention.

Effectiveness of a Mobile Short-Message-Service-Based Disease Outbreak Alert System in Kenya.

Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.

An in vitro evaluation of drugs used in the Kenyan ART program.

Understanding mSOS: A qualitative study examining the implementation of a text-messaging outbreak alert system in rural Kenya.

Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years.

Experience from a pilot point-of-care CD4 enumeration programme in Kenya.

Scale-up of Kenya's national HIV viral load program: Findings and lessons learned.

Health worker knowledge of Integrated Disease Surveillance and Response standard case definitions: a cross-sectional survey at rural health facilities in Kenya.

Leishmaniasis recidivans by Leishmania tropica in Central Rift Valley Region in Kenya.

Performance and usability evaluation of the INSTI HIV self-test in Kenya for qualitative detection of antibodies to HIV.

Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens.

Performance and usability of Cepheid GeneXpert HIV-1 qualitative and quantitative assay in Kenya.

Arboviruses in the East African Community partner states: a review of medically important mosquito-borne Arboviruses.

Seroprevalence of yellow fever, dengue, West Nile and chikungunya viruses in children in Teso South Sub-County, Western Kenya.

Performance and usability of mPIMA™ HIV 1/2 viral load test in point of care settings in Kenya.

Performance evaluation of the Aptima HIV-1 Quant Dx assay for detection of HIV in infants in Kenya.

Combating antibiotic resistance using guidelines and enhanced stewardship in Kenya: a protocol for an implementation science approach.

Tsetse distribution, trypanosome infection rates, and small-holder livestock producers' capacity enhancement for sustainable tsetse and trypanosomiasis control in Busia, Kenya.

Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya.

Zika virus pathogenesis and current therapeutic advances.

Developing multiplex ddPCR assays for SARS-CoV-2 detection based on probe mix and amplitude based multiplexing.

Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya.